Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Other financing activities (2016 - 2025)

Historic Other financing activities for Select Medical Holdings (SEM) over the last 15 years, with Q3 2025 value amounting to $2.1 million.

  • Select Medical Holdings' Other financing activities fell 4380.12% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.3 million, marking a year-over-year increase of 6208.67%. This contributed to the annual value of $15.7 million for FY2024, which is 3148.9% down from last year.
  • Per Select Medical Holdings' latest filing, its Other financing activities stood at $2.1 million for Q3 2025, which was down 4380.12% from $3.0 million recorded in Q2 2025.
  • Select Medical Holdings' 5-year Other financing activities high stood at $14.2 million for Q3 2021, and its period low was $141000.0 during Q3 2022.
  • In the last 5 years, Select Medical Holdings' Other financing activities had a median value of $3.3 million in 2024 and averaged $4.5 million.
  • Its Other financing activities has fluctuated over the past 5 years, first soared by 8115714.29% in 2021, then plummeted by 9900.97% in 2022.
  • Over the past 5 years, Select Medical Holdings' Other financing activities (Quarter) stood at $806000.0 in 2021, then skyrocketed by 201.99% to $2.4 million in 2022, then increased by 1.56% to $2.5 million in 2023, then skyrocketed by 154.85% to $6.3 million in 2024, then crashed by 67.33% to $2.1 million in 2025.
  • Its Other financing activities stands at $2.1 million for Q3 2025, versus $3.0 million for Q2 2025 and $7.9 million for Q1 2025.